The Role Microbiome and Oncolytic Viruses Play in Controlling Cancer

References (63)

1. 1 Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing [DOI]
2. 2 Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors [DOI]
3. 3 Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota [DOI]
4. 4 Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health [DOI]
5. 5 The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide [DOI]
6. 6 A History of Cancer Chemotherapy [DOI]
7. 7 Fat, fibre and cancer risk in African Americans and rural Africans [DOI]
8. 8 Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection [DOI]
9. 9 Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects [DOI]
10. 10 ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties [DOI]
11. 11 Microbiome and Malignancy [DOI]
12. 12 Dynamics of metatranscription in the inflammatory bowel disease gut microbiome [DOI]
13. 13 Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial [DOI]
14. 14 Gut Microbial Metabolism Drives Transformation of Msh2-Deficient Colon Epithelial Cells [DOI]
15. 15 Degradation of Fibrillar Collagen in a Human Melanoma Xenograft Improves the Efficacy of an Oncolytic Herpes Simplex Virus Vector [DOI]
16. 16 Role of Oral Microbiota in Cancer Development [DOI]
17. 17 The Human Microbiome and Cancer [DOI]
18. 18 Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies [DOI]
19. 19 Oncolytic viral therapies – the clinical experience [DOI]
20. 20 Seroprevalence of Epstein-Barr Virus Infection in U.S. Children Ages 6-19, 2003-2010 [DOI]
21. 21 Bacterial infections and cancer [DOI]
22. 22 Oral Microbiome: A New Biomarker Reservoir for Oral and Oropharyngeal Cancers [DOI]
23. 23 Epstein-Barr Virus Induces MCP-1 Secretion by Human Monocytes via TLR2 [DOI]
24. 24 Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing [DOI]
25. 25 Viral Carcinogenesis: Factors Inducing DNA Damage and Virus Integration [DOI]
26. 26 Merkel cell polyomavirus infection and Merkel cell carcinoma [DOI]
27. 27 Microbiota in cancer development and treatment [DOI]
28. 28 Targeted Large-Scale Deletion of Bacterial Genomes Using CRISPR-Nickases [DOI]
29. 29 Linoleic Acids Overproducing Lactobacillus casei Limits Growth, Survival, and Virulence of Salmonella Typhimurium and Enterohaemorrhagic Escherichia coli [DOI]
30. 30 Oncolytic herpes simplex virus vectors for cancer virotherapy [DOI]
31. 31 Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy.
32. 32 PHASE I STUDY OF INTRAVESICAL VACCINIA VIRUS AS A VECTOR FOR GENE THERAPY OF BLADDER CANCER [DOI]
33. 33 The Microbiome and Cancer: Is the ‘Oncobiome’ Mirage Real? [DOI]
34. 34 The impact of the intestinal microbiota in therapeutic responses against cancer [DOI]
35. 35 Helicobacter pylori Strains and Gastric MALT Lymphoma [DOI]
36. 36 Probiotic species in the modulation of the anticancer immune response [DOI]
37. 37 The emerging therapeutic potential of the oncolytic immunotherapeutic Pexa-Vec (JX-594) [DOI]
38. 38 Oncolytic Herpes Simplex Virus Vectors and Chemotherapy: Are Combinatorial Strategies More Effective for Cancer? [DOI]
39. 39 Viruses, Other Pathogenic Microorganisms and Esophageal Cancer [DOI]
40. 40 Treatment of non-muscle invasive bladder cancer with Bacillus Calmette–Guerin (BCG): Biological markers and simulation studies [DOI]
41. 41 Perspective on immune oncology with liquid biopsy, peripheral blood mononuclear cells, and microbiome with non-invasive biomarkers in cancer patients [DOI]
42. 42 The influence of the commensal microbiota on distal tumor-promoting inflammation [DOI]
43. 43 Replication-Selective Herpes Simplex Virus Type 1 Mutant Therapy of Cervical Cancer Is Enhanced by Low-Dose Radiation [DOI]
44. 44 Effect of Preexisting Anti-Herpes Immunity on the Efficacy of Herpes Simplex Viral Therapy in a Murine Intraperitoneal Tumor Model [DOI]
45. 45 MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomas [DOI]
46. 46 Multiomic Strategies Reveal Diversity and Important Functional Aspects of Human Gut Microbiome [DOI]
47. 47 Merkel cell polyomavirus in Merkel cell carcinogenesis: small T antigen-mediates c-Jun phosphorylation [DOI]
48. 48 Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection [DOI]
49. 49 Immunogenicity of nonreplicating recombinant vaccinia expressing HLA-A201 targeted or complete MART-1/Melan-A antigen [DOI]
50. 50 Harnessing the Tumor Microenvironment for the Treatment of Double Hit Lymphoma [DOI]
51. 51 The human tumor microbiome is composed of tumor type–specific intracellular bacteria [DOI]
52. 52 The microbiome, cancer, and cancer therapy [DOI]
53. 53 The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages [DOI]
54. 54 Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage [DOI]
55. 55 Exploring the emerging role of the microbiome in cancer immunotherapy [DOI]
56. 56 Commensal Enterobacteriaceae Protect against Salmonella Colonization through Oxygen Competition [DOI]
57. 57 Gut-Resident Lactobacilli Activate Hepatic Nrf2 and Protect Against Oxidative Liver Injury [DOI]
58. 58 International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis [DOI]
59. 59 Gut Microbiota beyond Bacteria—Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD [DOI]
60. 60 Microbiome in cancer progression and therapy [DOI]
61. 61 Gut microbiome and cancer immunotherapy [DOI]
62. 62 Pre‐existing heterologous T‐cell immunity and neoantigen immunogenicity [DOI]
63. 63 PHASE I STUDY OF INTRAVESICAL VACCINIA VIRUS AS A VECTOR FOR GENE THERAPY OF BLADDER CANCER [DOI]

Cited by 2

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

• Metal Based α-glucosidase Inhibitors: Synthesis, Characterization and α-glucosidase Inhibition Activity of Transition Metal Complexes — shares topic coverage
• Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): What Can Africa Learn from Ongoing Research in Epidemiology, Clinical Manifestations, Chemotherapy and Prevention? — shares topic coverage
• Mantle Cell Lymphoma of Gastrointestinal Tract as a Lead Point for Intussusception: A Case Report — shares topic coverage
• Antimalarial Drug Resistance: An Existential Burden for the Developing World — shares topic coverage
• Feline Mesenteric form of Multinodal Lymphoma: A Case Report — shares topic coverage